Study Summary
This is a single-center, single-arm, open, intravenous drug administration of the safety and efficacy of clinical study.
Want to learn more about this trial?
Request More InfoInterventions
CLL1/+CD33 CAR-TBIOLOGICAL
CLL1/+CD33 CAR T is a type of CAR T cell therapy for patients with treating/relapsed acute myeloid leukemia.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Fujian Provincial Children's Hospital | Fuzhou | Fujian | China |